BIXINK THERAPEUTICS

BIXINK Therapeutics creates a new treatment paradigm with creativity and innovation. The company intends to become a company that becomes the source of a healthier life through the construction and convergence of technology that encompasses the times.

#Financial #More

BIXINK THERAPEUTICS

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Font Awesome Mobile Non Scaleable Content Nginx Amazon Organization Schema Person Schema


Investments List

Date Company Article Money raised
2021-12-07 Limbix BIXINK Therapeutics investment in Series A - Limbix 15 M USD
2020-05-05 Limbix BIXINK Therapeutics investment in Series A - Limbix 9 M USD

More informations about "BIXINK Therapeutics"

BIXINK

May 24, 2020 BIXINK, Breast cancer adjuvant treatment 'Nerlynx' has entered into Big 5 General Hospital 0 0 21 Sep 2022 ... 0 0 20 Jul 2022 Views 4733 Bixink Therapeutics signs deals to โ€ฆSee details»

๋น…์”ฝํฌ l BIXINK

๋น…์”ฝํฌ, ็พŽ ์ฒญ์†Œ๋…„ ์šฐ์šธ์ฆ ๋””์ง€ํ„ธ ์น˜๋ฃŒ์ œ ๊ตญ๋‚ด ๋…์  ๊ณ„์•ฝ ์ฒด๊ฒฐSee details»

BIXINK Therapeutics - Crunchbase Investor Profile & Investments

BIXINK Therapeutics creates a new treatment paradigm with creativity and innovation. The company intends to become a company that becomes the source of a healthier life through the โ€ฆSee details»

BIXINK Therapeutics investment portfolio - PitchBook

BIXINK Therapeutics General Information Company Description. Founded in 2016, BIXINK Therapeutics is a venture capital investment firm based in Seoul, South Korea. The firm seeks โ€ฆSee details»

BIXINK Therapeutics - Investments, Portfolio & Company Exits

BIXINK Therapeutics has had . obfuscated. obfuscated. exit, which was Limbix. Which industries has this organization had the most exits in? Show . Limbix Limbix is a prescription digital โ€ฆSee details»

Subsidiaries of KPS - kpscorp.co.kr

BIXINK. BIXINK THERAPEUTICS is a new biopharmaceutical company aiming to develop a new treatment paradigm with creativity and innovation. The global market for therapeutic agents, โ€ฆSee details»

Bixink Therapeutics signs deals to expand DTx pipelines

May 24, 2022 Bixink Therapeutics is accelerating efforts to build a diverse digital therapeutics (DTx) portfolio by clinching a series of DTx deals. Bixink is a biotech subsidiary of KPS Corp. โ€ฆSee details»

Puma Biotechnology and Bixink Therapeutics Enter into Exclusive ...

Apr 30, 2020 Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Bixink Therapeutics, a new South Korean company working in the field of anti-cancer drugs โ€ฆSee details»

BIXINK

BIXINKSee details»

Bixink Therapeutics - VentureRadar

Bixink Therapeutics is a biotech subsidiary of KPS Corp that focuses on building a diverse digital therapeutics (DTx) portfolio. The company has signed several DTx deals, including an โ€ฆSee details»

MEDIA - BIXINK

Jul 20, 2022 Bixink Therapeutics signs deals to expand DTx pipelines Halimriadi Richar 24 May 2022 Views 5118 0; 12; Nerlynx in HER2-positive Early Breast Cancer, helping to overcome โ€ฆSee details»

Boryung and Bixink to co-market Nerlynx for HER2-positive breast โ€ฆ

Apr 4, 2024 Bixink Therapeutics has applied for health insurance benefits but has failed to get them. In the first year of its launch, Nerlynx reportedly generated 6 billion won in annual sales. โ€ฆSee details»

How will Nerlynx affect HER2-positive early breast cancer โ€ฆ

Jul 20, 2022 In 2021, Korean biotech firm Bixink Therapeutics introduced Nerlynx Tab. (neratinib), a HER2 inhibiting breast cancer treatment developed by Puma Biotechnology and โ€ฆSee details»

BIXINK

Bixink Therapeutics, a start-up biopharmaceutical company that creates new treatment paradigms through creativity and innovation, is growing through strengthening its internal compliance โ€ฆSee details»

MEDI:GATE NEWS ๋น…์”ฝํฌ, ์œ ๋ฐฉ์•” ์—ฐ์žฅ๋ณด์กฐ์š”๋ฒ• ์น˜๋ฃŒ์ œ ๋„ˆ๋ง์Šค์ • โ€ฆ

Sep 21, 2022 ๋น…์”ฝํฌํ…Œ๋ผํ“จํ‹ฑ์Šค(BIXINK THERAPEUTICS)๋Š” ์œ ๋ฐฉ์•” ์‹ ์•ฝ '๋„ˆ๋ง์Šค(Nerlynx)'๊ฐ€ 2์›” ์ถœ์‹œ ํ›„ ์„œ์šธ๋Œ€๋ณ‘์›๊ณผ ์„œ์šธ์•„์‚ฐ๋ณ‘์›, ์‚ผ์„ฑ์„œ์šธ๋ณ‘์›, ์„ธ๋ธŒ๋ž€์Šค๋ณ‘์›, ์„œ์šธ์„ฑ๋ชจ๋ณ‘์› ๋“ฑ ๋น…5 โ€ฆSee details»

Bixink Therapeutics - VentureRadar

Similar Companies: InStride Health USA Private InStride Health specializes in evidence-based outpatient treatment for pediatric anxiety and OCD. They offer a comprehensive approach that โ€ฆSee details»

Bixink Therapeutics and Professional Dietetics enter into โ€ฆ

Aug 5, 2021 Bixink Therapeutics and Professional Dietetics enter into partnership for the MUCOSAMIN® range, onco-supportive care, whereby Bixink will hold the exclusive โ€ฆSee details»

Will Nerlynx satisfy unmet demand for early breast cancer in Korea ...

Jan 20, 2022 Bixink Therapeutics emphasized that Nerlynx is the nationโ€™s first and only extended adjuvant therapy for HER2 positive early breast cancer. Park explained that the ultimate goal โ€ฆSee details»

2025-04-28 Acquisition of US Biopharma Company SpringWorks โ€ฆ

6 days ago SpringWorks Therapeutics is a U.S. biopharmaceutical company with a first-in-class, systemic standard-of-care therapy in adults with desmoid tumors and the first and only โ€ฆSee details»

BIXINK

Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer SymposiumSee details»